The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures
Open accessAbstract
PURPOSE: The increasing global risk of nuclear and radiological accidents or attacks has driven renewed research interest in developing medical countermeasures to potentially injurious exposures to acute irradiation. Clinical symptoms and signs of a developing acute radiation injury, i.e. the acute radiation syndrome, are grouped into three sub-syndromes named after the dominant organ system affected, namely the hematopoietic, gastrointestinal, and neurovascular systems. The availability of safe and effective countermeasures against the above threats currently represents a significant unmet medical need. This is the first article within a three-part series covering the nature of the radiation sub-syndromes, various animal models for radiation countermeasure development, and the agents currently approved by the United States Food and Drug Administration for countering the medical consequences of several of these prominent radiation exposure-associated syndromes. CONCLUSIONS: From the U.S. and global perspectives, biomedical research concerning medical countermeasure development is quite robust, largely due to increased government funding following the 9/11 incidence and subsequent rise of terrorist-associated threats. A wide spectrum of radiation countermeasures for specific types of radiation injuries is currently under investigation. However, only a few radiation countermeasures have been fully approved by regulatory agencies for human use during radiological/nuclear contingencies. Additional research effort, with additional funding, clearly will be needed in order to fill this significant, unmet medical health problem.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Waselenko, J. K., MacVittie, T. J., Blakely, W. F., Pesik, N., Wiley, A. L., Dickerson, W. E., Tsu, H., Confer, D. L., Coleman, C. N., Seed, T., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-12-200406150-00015 · Cited by 766 · cited 2×
“It is a result of the relative high radiosensitivities of committed progenitors in specific lineages of neutrophils and thrombocytes (Inoue et al. 1995; Goans et al. 1997; Dainiak 2002; Waselenko et al. 2004).”
BackgroundSelf-citationEffects of ionizing radiation on mitochondria
Kam, W. W.-Y., & Banati, R. B. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.024 · Cited by 386 · cited 8×
“Ionizing radiation is a DNA-damaging physical agent capable of causing lesions in cellular DNA, including double-strand breaks, single-strand breaks, DNA cross links, and more than 20 types of base damage.”
BackgroundInfluentialHematologic consequences of exposure to ionizing radiation
Dainiak, N. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00802-0 · Cited by 362
Filgrastim improves survival in lethally irradiated nonhuman primates
Farese, A. M., Cohen, M. V., Katz, B. P., Smith, C. P., Gibbs, A., Cohen, D. M., & MacVittie, T. J. (2013) · Radiation Research · doi:10.1667/rr3049.1 · Cited by 187
Bergonié, J., Tribondeau, L., & Bergonie, J. (1959) · Radiation Research · doi:10.2307/3570812 · Cited by 134
Pegfilgrastim improves survival of lethally irradiated nonhuman primates
Hankey, K. G., Farese, A. M., Blaauw, E. C., Gibbs, A. M., Smith, C. P., Katz, B. P., Tong, Y., Prado, K. L., & MacVittie, T. J. (2015) · Radiation Research · doi:10.1667/rr13940.1 · Cited by 129
Dainiak, N., Gent, R. N., Carr, Z., Schneider, R., Bader, J., Buglova, E., Chao, N., Coleman, C. N., Ganser, A., Gorin, C., et al. (2011) · Disaster Medicine and Public Health Preparedness · doi:10.1001/dmp.2011.68 · Cited by 107
Filgrastim for the treatment of hematopoietic acute radiation syndrome
Farese, A. M., & MacVittie, T. J. (2015) · Drugs of Today · doi:10.1358/dot.2015.51.9.2386730 · Cited by 95
Animal models for radiation injury, protection and therapy
Augustine, A. D., Gondré-Lewis, T., McBride, W., Miller, L., Pellmar, T. C., & Rockwell, S. (2005) · Radiation Research · doi:10.1667/rr3388 · Cited by 89
Moroni, M., Ngudiankama, B. F., Christensen, C., Olsen, C. H., Owens, R., Lombardini, E. D., Holt, R. K., & Whitnall, M. H. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.04.041 · Cited by 64
Cited by
On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology
Chou, D. B., Frismantas, V., Milton, Y., David, R., Pop-Damkov, P., Ferguson, D., MacDonald, A., Vargel Bölükbaşı, Ö., Joyce, C. E., Moreira Teixeira, L. S., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0495-z · Cited by 294
Singh, V. K., & Seed, T. M. (2021) · International Journal of Radiation Biology · doi:10.1080/09553002.2021.1969054 · Cited by 88
Self-citationBunin, D. I., Bakke, J., Green, C. E., Javitz, H. S., Fielden, M., & Chang, P. Y. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1605465 · Cited by 60
Zhong, Y., Pouliot, M., Downey, A.-M., Mockbee, C., Roychowdhury, D., Wierzbicki, W., & Authier, S. (2021) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1673499 · Cited by 52
Clayton, N. P., Khan-Malek, R. C., Dangler, C. A., Zhang, D., Ascah, A., Gains, M., Gardner, B., Mockbee, C., Keutzer, J. M., McManus, J., et al. (2020) · Radiation Research · doi:10.1667/rade-20-00131.1 · Cited by 52
Metadata
- Authors
- Singh, V. K., & Seed, T. M.
- Venue
- International Journal of Radiation Biology
- Publisher
- Informa UK Limited
- Published
- 2017-06-26
- Volume
- 93
- Issue
- 9
- Pages
- 851-869
- ISSN
- 0955-3002 (ISSN-L)
- 1362-3095
- OpenAlex
- W2680883357
- Cited by
- 175
- References
- 13
- FWCI
- 10.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures. https://app.cochat.ai/papers/10.1080/09553002.2017.1332438
- The paper
- Singh, V. K., & Seed, T. M. (2017). A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures. International Journal of Radiation Biology. https://doi.org/10.1080/09553002.2017.1332438
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.